Skip to main content
. 2021 Mar 31;51(1):2–9. doi: 10.28920/dhm51.1.2-9

Table 7. Risk factors for necrosis and re-operation. *Matsen et al.,[ 5] mild: no intervention needed, healing complete at eight weeks, moderate: office debridement, healing complete at eight weeks, severe: operating room debridement, implant loss, or healing not complete at 8 weeks. Results in bold are statistically significant.

Risk factor Degree of necrosis* Re-operation
Spearman’s rho P-value Odds’s ratio 95% CI
Age 0.241 0.092
BMI 0.268 0.060
Cup size -0.056 0.697
Previous or current smoking -0.004 0.976
Hypertension (n = 4) 0.043 0.766
Diabetes (n = 3) -0.046 0.751
Prior breast augmentation (n = 5) -0.175 0.225
Previous breast reduction (n = 3) 0.286 0.044
Previous radiation therapy (n = 11) 0.302 0.033 7.2 1.4−37.3
Previous chemotherapy (n = 14) 0.153 0.288
Infection (n = 12) 0.443 0.001 15.4 2.6−89.7
Nipple-sparing mastectomy (n = 22) 0.011 0.939
Hammond (n = 17) -0.013 0.927
Weight of mastectomy specimen 0.173 0.229
Use of an acellular dermal matrix (n = 3) 0.029 0.843
Number of days of delay to HBOT -0.166 0.250
Total number of sessions of HBOT 0.130 0.367